www.fdanews.com/articles/197530-avalon-globocare-teams-up-with-genskey-for-covid-19-tests
![team up](https://www.fdanews.com/ext/resources/test/Device_Images5/team-up-text.gif?t=1590011221&width=430)
Avalon GloboCare Teams Up with GensKey for COVID-19 Tests
June 9, 2020
New Jersey-based Avalon GloboCare is collaborating with China’s GensKey Medical Technology to develop and market a COVID-19 rapid antibody test and a separate polymerase chain reaction (PCR)-based diagnostic.
The antibody tests are used to determine whether a patient has been exposed to the virus and has developed antibodies, while the PCR test is used to diagnose infected patients.
The two diagnostics have already received CE mark certification and are awaiting an Emergency Use Authorization from the FDA. Avalon said it will establish a manufacturing facility in the U.S. to produce the tests.